Israeli HIV+ surgeon cleared to continue work
Israeli HIV+ surgeon cleared to continue work
Provider-to-patient transmission exceedingly rare
In a case that recalls the national hue and cry of the Florida HIV dental outbreak in the early 1990s, investigators have determined that HIV provider-to-patient infections remain exceedingly rare.
A surgeon in Israel was found to be HIV-positive in January 2007 during evaluation for fever of recent onset. The duration of infection was unknown. A look-back investigation of patients operated on by the infected surgeon during the preceding 10 years was conducted under the auspices of the Israel Ministry of Health to determine whether any surgeon-to-patient HIV transmission had occurred. Of 1,669 patients identified, 545 (33%) underwent serologic testing for HIV antibody. All results were negative.
"The results of this investigation add to previously published data indicating a low risk for provider-to-patient HIV transmission," the Centers for Disease Control and Prevention reported.1
After considering the clinical details of the surgeon's case, the published literature on HIV transmission from infected health care workers to patients, and the findings of this investigation, a review panel recommended allowing the resumption of work, with no restrictions on the types of procedures the surgeon could perform, provided the surgeon met the following conditions:
- Instruction by infection control personnel at the surgeon's hospital regarding safe practices, including adherence to standard precautions and hand hygiene requirements, double-gloving during all surgery, and immediate reporting of any cuts in gloves or fingersticks, plus agreement by the surgeon to abide by these practices.
- Routine health care follow-up at three-month intervals, including measurement of CD4 T-cell count and HIV RNA.
- Adherence to a prescribed antiretroviral regimen, maintenance of good health, and continued CD4 T-cell level > 200 cells/µL, with HIV RNA below the threshold of detection.
On the basis of the published literature, the panel did not require notification of prospective patients of the surgeon's HIV status because of the extremely low likelihood of transmission to patients if the conditions for resuming surgery were met, the CDC concluded.
The conditions were consistent with the recommendations contained in the position paper of the Society for Healthcare Epidemiology of America in 1997.2 By agreement with the surgeon and the administration at the hospital of current employment, an infection control physician on the hospital's staff familiar with the case was charged with ensuring compliance with these conditions. As of June 2008, none of the 1,669 patients included in the initial contact list was listed in the national HIV registry.
In the early 1990s, CDC reported on six patients infected by a Florida dentist.3 Subsequently, only three additional cases have been reported:
- probable transmission from an orthopedic surgeon to a patient in France;
- probable transmission from a nurse to a patient, also in France;
- probable transmission from a gynecologist to a patient during a cesarean delivery in Spain.4
In 1991, CDC issued guidelines to prevent transmission of HIV and hepatitis B virus (HBV) to patients, which required health care workers infected with either of these viruses to refrain from performing exposure-prone procedures before obtaining counsel from a review panel and to notify prospective patients of the health care worker's seropositivity before performing exposure-prone invasive procedures.5 The guidelines provide general characteristics of exposure-prone procedures, which include digital palpation of a needle tip in a body cavity or the simultaneous presence of the health care worker's fingers and a needle or other sharp instrument or object in a poorly visualized or highly confined anatomic site. Although medical organizations and institutions are advised to identify specific procedures falling into this category, the guidelines include types of invasive surgical procedures that should be considered exposure-prone. Regarding retrospective notification of patients who have had exposure-prone procedures performed on them by infected health care workers, the guidelines note that more data are needed to determine the risk for transmission during such procedures. The guidelines say notification should be considered on a case-by-case basis, and it should take into consideration an assessment of specific risks, confidentiality issues, and available resources.
During the 17 years since the CDC guidelines were issued, data based on published look-back investigations of bloodborne pathogen outbreaks and mathematical modeling indicate that the risk for transmission of HIV from an infected surgeon to a patient is considerably lower than that for HBV or hepatitis C virus. The degree of blood infectivity of HIV carriers has been shown to vary, in part, as a function of viral load, which now can be rendered undetectable via use of antiretroviral regimens that were unavailable at the time the guidelines were issued.
- Centers for Disease Control and Prevention. Investigation of patients treated by an HIV-infected cardiothoracic surgeon — Israel, 2007. MMWR 2009; 57(53):1,413-1,415.
- D4+ Recovery in HIV-1 Infected Patients is Independent of Class of Antiretroviral Therapy. AIDS/TB Committee of the Society for Healthcare Epidemiology of America. Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. Infect Control Hosp Epidemiol 1997; 18:349-363.
- CDC. Update: Investigations of persons treated by HIV-infected health-care workers — United States. MMWR 1993; 42:329-331, 337.
- Perry JL, Pearson RD, Jagger J. Infected health care workers and patient safety: A double standard. Am J Infect Control 2006; 34:313-319.
- Centers for Disease Control and Prevention. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR 1991; 40(No. RR-8).
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.